Andrew Saich

Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX.

Seqirus Vaccines Ltd. manufactures vaccines. The company is headquartered in Maidenhead, the United Kingdom.

Diligence, Inc. provides business intelligence and analysis services. Its expertise include investigations, due diligence, forensics, business intelligence, personnel screening, and business resilience and continuity. The company was founded in 2000 and is headquartered in New York, NY.

ALTANA Pharma US, Inc. develops respiratory and gastrointestinal products. The company is headquartered in Florham Park, NJ.

Shield Holdings AG develops and commercializes late stage pharma products. The company was founded by Carl Sterritt and Christian Schweiger in 2008 and is headquartered in Wollerau, Switzerland.

Senzer Ltd. is a British UK-based inhalation technology company founded in 2015. Senzer's location is in Salisbury, UK. The private company specializes in developing and commercializing therapeutic delivery systems of cannabinoid products. Senzer's platform is based on a patented device that allows swift and effective inhaled delivery of cannabinoids in a consistent dose-controlled presentation. The company is developing a pipeline of inhalation and delivery products to meet unmet medical needs.